Antibody-Drug Conjugates

Antibody-drug conjugates (ADCs) are targeted cancer therapies that combine an antibody specific to cancer cells with a cytotoxic drug. The antibody component allows for precise delivery of the drug to cancer cells, minimizing damage to healthy cells. This targeted approach is significant for longevity and health optimization as it offers a more effective and less toxic cancer treatment option.